Adell Harriman & Carpenter’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,842
| Closed | -$2.3M | – | 159 |
|
|
2024
Q1 | $2.3M | Sell |
28,842
-8,915
| -24% | -$681K | 0.19% | 83 |
|
|
2023
Q4 | $2.98M | Sell |
37,757
-16,577
| -31% | -$1.18M | 0.28% | 76 |
|
|
2023
Q3 | $3.79M | Sell |
54,334
-25,924
| -32% | -$1.84M | 0.39% | 65 |
|
|
2023
Q2 | $5.6M | Sell |
80,258
-37,216
| -32% | -$2.65M | 0.57% | 51 |
|
|
2023
Q1 | $8.73M | Sell |
117,474
-16,364
| -12% | -$1.37M | 0.94% | 37 |
|
|
2022
Q4 | $12.5M | Buy |
133,838
+7,625
| +6% | +$736K | 1.43% | 23 |
|
|
2022
Q3 | $12M | Buy |
126,213
+4,945
| +4% | +$489K | 1.46% | 21 |
|
|
2022
Q2 | $11.2M | Sell |
121,268
-2,597
| -2% | -$253K | 1.38% | 24 |
|
|
2022
Q1 | $12.5M | Sell |
123,865
-474
| -0.4% | -$49.8K | 1.22% | 26 |
|
|
2021
Q4 | $12.8M | Buy |
124,339
+9,387
| +8% | +$867K | 1.19% | 28 |
|
|
2021
Q3 | $9.75M | Buy |
114,952
+1,744
| +2% | +$146K | 1.02% | 32 |
|
|
2021
Q2 | $9.45M | Buy |
113,208
+10,340
| +10% | +$847K | 0.99% | 32 |
|
|
2021
Q1 | $7.74M | Buy |
102,868
+10,045
| +11% | +$732K | 0.94% | 38 |
|
|
2020
Q4 | $6.34M | Buy |
92,823
+185
| +0.2% | +$12K | 0.83% | 43 |
|
|
2020
Q3 | $5.41M | Buy |
92,638
+11,447
| +14% | +$712K | 0.81% | 40 |
|
|
2020
Q2 | $5.27M | Buy |
81,191
+56,175
| +225% | +$3.54M | 0.9% | 37 |
|
|
2020
Q1 | $1.48M | Buy |
25,016
+5,180
| +26% | +$346K | 0.31% | 75 |
|
|
2019
Q4 | $1.47M | Buy |
19,836
+5,620
| +40% | +$395K | 0.24% | 81 |
|
|
2019
Q3 | $897K | Buy |
14,216
+2,300
| +19% | +$136K | 0.16% | 92 |
|
|
2019
Q2 | $649K | Buy |
11,916
+1,609
| +16% | +$86.6K | 0.12% | 95 |
|
|
2019
Q1 | $556K | Sell |
10,307
-777
| -7% | -$48K | 0.11% | 97 |
|
|
2018
Q4 | $726K | Buy |
11,084
+6,814
| +160% | +$509K | 0.16% | 96 |
|
|
2018
Q3 | $336K | Sell |
4,270
-175
| -4% | -$12.5K | 0.06% | 130 |
|
|
2018
Q2 | $286K | Buy |
+4,445
| New | +$293K | 0.06% | 133 |
|
|
2018
Q1 | – | Sell |
-3,070
| Closed | -$223K | – | 148 |
|
|
2017
Q4 | $223K | Sell |
3,070
-100
| -3% | -$7.27K | 0.05% | 135 |
|
|
2017
Q3 | $258K | Sell |
3,170
-95
| -3% | -$7.51K | 0.06% | 128 |
|
|
2017
Q2 | $263K | Buy |
3,265
+1
| +0% | +$79 | 0.06% | 129 |
|
|
2017
Q1 | $256K | Buy |
3,264
+495
| +18% | +$39.5K | 0.06% | 128 |
|
|
2016
Q4 | $219K | Buy |
+2,769
| New | +$224K | 0.05% | 129 |
|
|
2016
Q3 | – | Sell |
-2,300
| Closed | -$220K | – | 133 |
|
|
2016
Q2 | $220K | Sell |
2,300
-10
| -0.4% | -$997 | 0.06% | 128 |
|
|
2016
Q1 | $240K | Hold |
2,310
| – | – | 0.06% | 126 |
|
|
2015
Q4 | $226K | Hold |
2,310
| – | – | 0.06% | 127 |
|
|
2015
Q3 | $223K | Hold |
2,310
| – | – | 0.07% | 131 |
|
|
2015
Q2 | $242K | Hold |
2,310
| – | – | 0.06% | 133 |
|
|
2015
Q1 | $238K | Hold |
2,310
| – | – | 0.06% | 126 |
|
|
2014
Q4 | $222K | Buy |
+2,310
| New | +$204K | 0.06% | 121 |
|
Other funds holding CVS
Adell Harriman & Carpenter's CVS Position: Q2 2024 in Review
Adell Harriman & Carpenter sold out of CVS Health (CVS) in Q2 2024, closing a stake of 28,842 shares — an estimated $2.3M sold.
Adell Harriman & Carpenter first reported a position in CVS in Q4 2014 and held it in 36 quarters. The position peaked at $12.8M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Adell Harriman & Carpenter reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Adell Harriman & Carpenter sold 28,842 CVS Health shares in Q2 2024, an estimated $2.3M.
- Adell Harriman & Carpenter first reported a position in CVS Health in Q4 2014 and held it in 36 quarters.
- Adell Harriman & Carpenter's CVS Health position peaked at $12.8M in Q4 2021.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Adell Harriman & Carpenter's 13F filing for Q2 2024, filed 1 Aug 2024.